Chronic lymphocytic leukaemia: open trials in New Zealand

• NCT05947851

  A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  North Shore Hospital-Department of Haematology (Site 3505), Auckland · Aotearoa Clinical Trials (Site 3504), Auckland · Christchurch Hospital (Site 3503), Christchurch · Palmerston North Hospital (Site 3506), Palmerston North

  Registry updated 2026-11-06

• NCT06943872

  A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

  Trial Treatment · Phase 3 · BeOne Medicines

  Auckland City Hospital, Auckland · North Shore Hospital, Auckland

  Registry updated 2026-10-23

• NCT06136559

  A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  North Shore Hospital-Department of Haematology (Site 3200), Auckland · Aotearoa Clinical Trials (Site 3201), Auckland · Waikato Hospital-Haematology (Site 3202), Hamilton

  Registry updated 2026-10-13

• NCT06973187

  A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  Trial Treatment · Phase 3 · BeOne Medicines

  North Shore Hospital, Auckland · Tauranga Hospital, Tauranga · Wellington Regional Hospital (Ccdhb), Wellington

  Registry updated 2026-09-28

• NCT07277231

  A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

  Trial Treatment · Phase 3 · BeOne Medicines

  North Shore Hospital, Auckland · Auckland City Hospital, Auckland · Health New Zealand Canterbury, Christchurch · Dunedin Hospital, Dunedin · Wellington Regional Hospital (Ccdhb), Wellington

  Registry updated 2026-09-28

• NCT05254743

  A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  Trial Treatment · Phase 3 · Loxo Oncology, Inc.

  Dunedin Hospital, Dunedin · Waikato Hospital, Hamilton · Momentum Clinical Research, Newtown · Middlemore Clinical Trials, Papatoetoe

  Registry updated 2026-08-17

All Chronic lymphocytic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error